Table 2.
A selection of recent cumulative exposure studies from populations in North America and Europe, including exposures to six chemical classes (phthalates, phenols, perfluorinated compounds (PFCs), flame retardants, polychlorinated biphenyls (PCBs), organochlorine pesticides (OCs)
Study | n | location | years | matrix1 | Classes measured | ||||
---|---|---|---|---|---|---|---|---|---|
phthalates | phenols | PFCs | Flame retardants | PCBs & OCs | |||||
Maternal Serum (MS) | |||||||||
Abdelouahab et al. 2013 [136] | 380 | Canada | 2007–08 | MS | x | x | |||
Adlard et al. 2014 [118] | 363 | Canada, Mexico | 2005–2007 | MS | x | x | |||
Carmichael et al. 2010 [137] | 48 | USA | 2003 | MS | x | x | |||
Cheslack-Postava et al. 2013 [88] | 150 | Finland | 1991–2000 | MS | x | x | |||
Roze et al. 2009 [151] | 62 | Netherlands | 2001–02 | MS | x | x | |||
Vafeiadi et al. 2014 [95] | 1117 | Greece | 2007–08 | MS | x | x | |||
Vorkamp et al. 2014 [138] | 100 | Denmark | 2011 | MS | x | x | |||
Zota et al. 2013 [82] | 61 | USA | 2008–12 | MS | x | x | |||
Maternal urine (MU) | |||||||||
Arbuckle et al. 2014 [152] | 2000 | Canada | 2008–11 | MU | x | x | |||
Braun et al. 2012 [153] | 137 | USA | 2004–09 | MU | x | x | |||
Braun et al. 2014 [154] | 177 | USA | 2005–11 | MU | x | x | |||
Casas et al. 2011 [134] | 120 | Spain | 2004–08 | MU | x | x | |||
Tefre de Renzy-Martin et al. 2014 [132] | 200 | Denmark | 2011 | MU | x | x | |||
Ferguson et al. 2014 [155] | 107 | Mexico | 1994–2004 | MU | x | x | |||
Hoepner et al. 2013 [145] | 375 | USA | 1999–2006 | MU | x | x | |||
Phillipat et al. 2012 [133] | 191, 287 | France | 2002–06 | MU | x | x | |||
Watkins et al. 2014 [156] | 116 | Mexico | 1997–2004 | MU | x | x | |||
Weinberger et al. 2014 [157] | 72 | USA | not listed | MU | x | x | |||
Breast Milk (BM) | |||||||||
Alivernini et al. 2011 [158] | 13 | Italy | 2005–2007 | BM | x | x | |||
Croes et al. 2012 [141] | 84 | Belgium | 2009–10 | BM | x | x | |||
Gómara et al. 2011 [159] | 9 | Spain | 2005 | BM | x | x | |||
Hernik et al. 2011 [100] | 28 | Poland | 2002–05 | BM | x | x | |||
LaKind et al. 2009 [97] | 10 | USA | 2004–05 | BM | x | x | |||
Lankova et al. 2013 [55] | 50 | Czech Republic | 2010 | BM | x | x | |||
Lignell et al. 2009 [140] | 335 | Sweden | 1996–2006 | BM | x | x | |||
Park et al. 2011 [143] | 82 | USA | 2003–05 | BM | x | x | |||
Pratt et al. 2013 [160] | 109 | Ireland | 2010 | BM | x | x | |||
Raab et al. 2013 [101] | 516 | Germany | 2007–08 | BM | x | x | |||
Schlumpf et al. 2010 [121] | 54 | Switzerland | 2004–06 | BM | x | x | x | x | |
Schuhmacher et al. 2008 [144] | 15 | Spain | 2007 | BM | x | x | |||
Thomsen et al. 2010 [62] | 70 | Norway | 2001–09 | BM | x | x | x | ||
Cord Serum (CS) | |||||||||
Arbuckle et al. 2013 [139] | 126 | Canada | 2005–08 | CS | x | x | |||
Chevalier et al. 2015 [19] | 180 | France | 2002–05 | CS | x | x | x | ||
Vizcaino et al. 2011 [161] | 265 | Spain | 1997–98 | CS | x | x | |||
Placenta (P) and Amniotic Fluid (AF) | |||||||||
Leino et al. 2013 [107] | 130 | Finland | 2004–2005 | P | x | x | |||
Nanes et al. 2014 [162] | 42 | USA | not listed | P | x | x | |||
Jensen et al. 2012 [18] | 300 | Denmark | 1980–96 | AF | x | x | |||
Multiple matrices | |||||||||
Braun et al. 2014 [142] | 175 | USA | 2003–06 | MU, MS | x | x | x | x | x |
Brucker-Davis et al. 2011 [163] | 69, 84 | France | 2002–05 | BM, CS | x | x | |||
de Cock et al. 2014 [56] | 83 | Netherlands | 2011–13 | CS, BM | x | x | x | ||
Doucet et al. 2009 [164] | 52, 60 | Canada | 1998–2006 | P, fetal liver | x | x | |||
Needham et al. 2011 [57] | 15 | Faroe Islands | 2000 | MS, BM, CS, P | x | x | |||
Porpora et al. 2013 [165] | 38 | Italy | 2008–09 | MS, CS | x | x | |||
Vizcaino et al. 2014 [135] | 308, 50 | Spain | 2004–08 | MS, CS, P | x | x | |||
Woodruff et al. 2011 [2] | 268 | USA | 2003–04 | MU, MS | x | x | x | x | x |
Matrix abbreviations: MS: maternal serum; MU: maternal urine; BM: breast milk; CS: cord serum; P: placenta; AF: amniotic fluid